Literature DB >> 17170536

Diabetes: changing the fate of diabetics in the dialysis unit.

Behrooz Broumand1.   

Abstract

The prevalence of diabetes mellitus (DM) is very high worldwide. According to the World Health Organization in 2000 the worldwide prevalence of DM was 171,000,000. Diabetic nephropathy is a major vascular complication of DM. If DM is not treated early and adequately, many diabetic patients may reach end-stage renal disease (ESRD) secondary to advanced irreversible diabetic nephropathy. In many countries diabetic nephropathy has become the single most frequent cause of prevalent ESRD patients undergoing maintenance hemodialysis (MHD). In the early era of renal replacement therapy (RRT) by means of intermittent hemodialysis the prognosis of diabetic patients undergoing MHD was extremely poor and disappointing. While the prognosis of patients suffering from diabetic ESRD and maintained by chronic intermittent dialysis has greatly improved, the rehabilitation rate and survival of these patients continue to be worse than those of non-diabetic patients. A preexisting severely compromised cardiovascular condition, vascular access problems, diabetic foot disease, interdialytic weight gain, and intradialytic hypotension explain most of the less favorable outcome. Despite improved techniques and more aggressive medical therapy in recent years, a review of the fate of diabetics in dialysis units since 1972 reveals that these patients have had significant morbidity and mortality. We still have a long way to go in order to achieve more ideal outcomes for our patients. Most of the diabetic ESRD patients are still maintained by MHD, but they can choose other modalities of RRT such as chronic ambulatory peritoneal dialysis (CAPD), kidney and kidney plus pancreas transplantation. The results of different studies and national registries on the mortality and morbidity of ESRD patients being maintained on different modalities of dialysis are conflicting. It can be concluded that the two modalities of dialysis (CAPD and MHD) are almost comparable in terms of survival. The recent suggestions for nocturnal daily hemodialysis, short daily hemodialysis, and an integrative care approach for the management of diabetics with ESRD provides better promise for these patients. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170536     DOI: 10.1159/000096396

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

Review 1.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

2.  Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy.

Authors:  Li Qin Tang; Sheng Liu; Shan Tang Zhang; Ling Na Zhu; Feng Ling Wang
Journal:  Mol Biol Rep       Date:  2014-02-01       Impact factor: 2.316

Review 3.  Metabolomics in the study of kidney diseases.

Authors:  Robert H Weiss; Kyoungmi Kim
Journal:  Nat Rev Nephrol       Date:  2011-10-25       Impact factor: 28.314

4.  Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition.

Authors:  Weihua Liu; Futian Tang; Yanhui Deng; Xuejuan Li; Tian Lan; Xiaoyan Zhang; Heqing Huang; Peiqing Liu
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

Review 5.  Lipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitus.

Authors:  Fernando H G Tessaro; Thais S Ayala; Joilson O Martins
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

6.  Improving outcomes in patients with coexisting multimorbid conditions-the development and evaluation of the combined diabetes and renal control trial (C-DIRECT): study protocol.

Authors:  Konstadina Griva; Nandakumar Mooppil; Eric Khoo; Vanessa Yin Woan Lee; Augustine Wee Cheng Kang; Stanton P Newman
Journal:  BMJ Open       Date:  2015-02-12       Impact factor: 2.692

7.  Hemodialysis outcomes and practice patterns in end-stage renal disease: Experience from a Tertiary Care Hospital in Kerala.

Authors:  G R Lakshminarayana; L G Sheetal; A Mathew; R Rajesh; G Kurian; V N Unni
Journal:  Indian J Nephrol       Date:  2017 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.